Primary source: What is an Early Alert?
The recall now includes additional lot numbers, increasing the scope of affected products that must be quarantined and destroyed.
Continued use of these catheters may lead to serious injuries or fatalities due to potential infection or embolism risks associated with the residual particulates.
Immediate quarantine and destruction of all affected lots are mandated. Affected inventory must be checked, and customers must be notified if products have been resold or transferred.
Regulatory Intelligence Lead
Review in the next regulatory intelligence cycle.
Immediate quarantine and destruction of all affected lots are mandated. Affected inventory must be checked, and customers must be notified if products have been resold or transferred.
Medline Industries is recalling certain reprocessed electrophysiology and ultrasound catheters identified as potentially containing residual particulates, risking serious health complications if used. This recall has been classified as Class I, indicating it is the most serious type.
What changed: The recall now includes additional lot numbers, increasing the scope of affected products that must be quarantined and destroyed.
Why it matters: Continued use of these catheters may lead to serious injuries or fatalities due to potential infection or embolism risks associated with the residual particulates.
Practical implication: Immediate quarantine and destruction of all affected lots are mandated. Affected inventory must be checked, and customers must be notified if products have been resold or transferred.
Published from the regulator source ingestion pipeline after PV impact triage.
Healthcare providers must implement the new administration protocol for Zanvastro, which is an injection every three months, and monitor for common side effects such as vomiting, back pain, and signs of aseptic meningitis.
Stakeholders must familiarize themselves with the new data elements for Individual Case Safety Reports (ICSRs) as per the revised EudraVigilance access policy effective immediately.
Ensure that all labeling and safety information reflects the updated product name 'Prasugrel Viatris' instead of 'Prasugrel Mylan'.
The program will implement collaborative processes for the evaluation of technologies, enhancing real-world evidence integration into signal management and impacting regulatory compliance workflows.
